Drug intelligence / Profile preview

5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-piperazin-1-yl-1H-pyrazole-3-carboxamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the chemical formula C16H20ClN5O3 and a molecular weight of approximately 365.8 g/mol. It features a pyrazole core substituted with a piperazine ring and an N‑ethyl carboxamide group, as well as a chlorinated dihydroxyphenyl moiety. The structure suggests it is part of the phenylpyrazole class of compounds. There is no evidence that this molecule has been approved for any therapeutic use or entered clinical trials; its primary identification in chemical databases indicates it may be used in research settings as a tool compound or lead structure for further drug development[1][6][7]. No mechanism of action or biological target has been definitively established in public sources.

Other names
5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-piperazin-1-YL-1H-pyrazole-3-carboxamide3-(5-chloro-2,4-dihydroxyphenyl)-N‑ethyl‑4‑piperazin‑1‑yl‑1H‑pyrazole‑5-carboxamide
02

Targets

PK (Pyruvate kinase)

Beyond the preview

Go deeper on 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-piperazin-1-yl-1H-pyrazole-3-carboxamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-piperazin-1-yl-1H-pyrazole-3-carboxamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call